2014
DOI: 10.1016/j.anai.2013.12.011
|View full text |Cite
|
Sign up to set email alerts
|

Urinary biopyrrin: a potential inflammatory marker of atopic dermatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 6 publications
0
3
0
Order By: Relevance
“…To the best of our knowledge, this is the first clinical report to analyze the urinary levels of biopyrrins in psoriasis. Increased urinary biopyrrins was reported in atopic dermatitis,[ 23 ] heart failure,[ 24 ] acute myocardial infarction,[ 25 ] asthma[ 26 ] unconjugated hyperbilirubinemia[ 27 ] perinatal stress[ 28 ] and in workers with asbestos exposure. [ 29 ]…”
Section: Discussionmentioning
confidence: 99%
“…To the best of our knowledge, this is the first clinical report to analyze the urinary levels of biopyrrins in psoriasis. Increased urinary biopyrrins was reported in atopic dermatitis,[ 23 ] heart failure,[ 24 ] acute myocardial infarction,[ 25 ] asthma[ 26 ] unconjugated hyperbilirubinemia[ 27 ] perinatal stress[ 28 ] and in workers with asbestos exposure. [ 29 ]…”
Section: Discussionmentioning
confidence: 99%
“…Biopyrrins served as markers of oxidative stress in various studies. The inherent biological activity of these oxidation products is still not understood. Structurally related tripyrrindiones also suggest interesting chemical properties for this class of molecules .…”
Section: Resultsmentioning
confidence: 99%
“…Atopic dermatitis (AD) is a chronic and relapsing eczematous disease generally associated with allergen-induced skin inflammation. Chronic persistent inflammation due to both free radical and inappropriate T helper (Th) cell activation by estrogen decrease is postulated to impair the skin barrier function and to modulate the immunological profile of AD [14, 15]. Clinically, the exacerbation of cutaneous symptoms in AD is known to be associated with menstruation, when estrogen declines [16].…”
Section: Introductionmentioning
confidence: 99%